Immuneering Corporation (IMRX) Misses Q4 EPS by 13c

Immuneering Corporation (NASDAQ: IMRX) reported Q4 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• OpenAI launches cybersecurity tools and open-source patching program
• OpenAI launches open-source security program with Trail of Bits